For each cancer type, headings corresponding to studies showing: HGF/SF expression in tumour biopsies; Met expression in tumour biopsies; expression of HGF/SF or Met correlating with poor prognosis; sporadic or germline-activating mutations in Met; tumour cells expressing Met or HGF/SF in vitro; animal models supporting the role of Met and HGF/SF in cancer, including human tumour xenografts in immunecompromised mice, mice with HGF/SF or Met transgenes, or other animal models displaying dependence on HGF/SF or Met in cancer development; therapeutic developments; HGF/SF-MET Reviews;
Clicking the column or row headings will display all appropriate references for the chosen category or cancer type.
|
|